As of 2024-12-13, the Intrinsic Value of InMed Pharmaceuticals Inc (IN.TO) is
-16.08 CAD. This IN.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 4.19 CAD, the upside of InMed Pharmaceuticals Inc is
-483.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-16.08 CAD
Intrinsic Value
IN.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-16.08 - -16.08 |
-16.08 |
-483.70% |
| DDM - Stable |
(12.32) - (52.57) |
(32.45) |
-874.4% |
| DDM - Multi |
(13.50) - (45.66) |
(20.94) |
-599.9% |
IN.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
33.73 |
| Beta |
2.27 |
| Outstanding shares (mil) |
8.05 |
| Enterprise Value (mil) |
19.99 |
| Market risk premium |
4.74% |
| Cost of Equity |
8.74% |
| Cost of Debt |
5.00% |
| WACC |
8.68% |